BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

National Institute on Drug Abuse (NIDA) 

6001 Executive Boulevard

Bethesda  Maryland  20892-9561  U.S.A.
Phone: 301-443-1124 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Government






 Company News
Technical Resources International, Inc. And Nuventra Pharma Sciences To Provide Pharmacokinetic And Pharmacodynamic Services To The National Institute on Drug Abuse (NIDA) 7/8/2014 6:40:27 AM
Initial Data From Lightlake Therapeutics Inc. (LLTP) Joint Clinical Trial With National Institute on Drug Abuse (NIDA) Shows Nasal Delivery Of Naloxone For Opioid Overdose As A Promising Treatment 12/4/2013 11:10:42 AM
Addex Therapeutics (ADXN.SW) and National Institute on Drug Abuse (NIDA) Enter Collaboration to Advance ADX71441 & ADX88178 in Drug Abuse and Addiction 11/4/2013 9:39:09 AM
Lightlake Therapeutics Inc. (LLTP) Commences Two-Week Patient Trial for Treatment of Opioid Overdose With National Institute on Drug Abuse (NIDA) 9/24/2013 10:14:15 AM
Lightlake Therapeutics Inc. (LLTP) Announces Partnership With National Institute on Drug Abuse (NIDA) to Treat Opioid Overdose 8/21/2013 9:35:04 AM
Lightlake Therapeutics Inc. (LLTP) to Develop Opioid Drug Treatment in Collaboration With the National Institute on Drug Abuse (NIDA) 4/24/2013 11:32:09 AM
Dalton Medicinal Chemistry Partners Receives Notice of Award From National Institute on Drug Abuse (NIDA) of National Institutes of Health (NIH) to Fund Research 3/27/2013 11:49:47 AM
Rats, Like Humans, Return to Drinking Once Punishment is Removed, National Institute on Drug Abuse (NIDA) Study 1/31/2013 7:33:05 AM
Brain Area's Role in Learning Identified, University of Maryland and National Institute on Drug Abuse (NIDA) Study 11/27/2012 7:09:31 AM
Dr. Brad Vince & Associates Announces Award of Nearly $10 Million Contract From the National Institute on Drug Abuse (NIDA) 9/18/2012 11:18:45 AM
12345